Home › NDC Lookup › Labelers › Medexus Pharma, Inc.

Medexus Pharma, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 59137 (Medexus Pharma, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

26
Package NDCs
19
Products
19
Active listings
0
Discontinued
5
Ingredients
0
Therapeutic classes
5
Dosage forms
7
With NADAC pricing

Portfolio

Top ingredients
methotrexate 9
coagulation factor IX (recombinant... 6
treosulfan 2
AMINOLEVULINIC ACID HYDROCHLORIDE 1
triamcinolone hexacetonide 1
By dosage form
INJECTION, SOLUTION 9
KIT 6
INJECTION, POWDER, LYOPHILIZED, FO... 2
POWDER, FOR SOLUTION 1
INJECTION, SUSPENSION 1

Browse records — 19 products

Drug / product Billing NDC NADAC / unit Status
GLEOLAN AMINOLEVULINIC ACID HYDROCHLORIDE 1500 mg/1 POWDER, FOR SOLUTION Medexus · NDC 59137-0231-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (59137-231-01) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE 59137-0231-01 — Discontinued View →
GRAFAPEX treosulfan 5000 mg/5g INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Medexus · NDC 59137-0365-01 · J0614 · 1 VIAL in 1 CARTON (59137-365-01) / 5 g in 1 VIAL 59137-0365-01 — On market View →
GRAFAPEX treosulfan 1000 mg/g INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Medexus · NDC 59137-0335-01 · J0614 · 1 VIAL in 1 CARTON (59137-335-01) / 1 g in 1 VIAL 59137-0335-01 — On market View →
Hexatrione 2% triamcinolone hexacetonide 40 mg/2mL INJECTION, SUSPENSION Medexus · NDC 59137-0570-01 · 1 AMPULE in 1 CARTON (59137-570-01) / 2 mL in 1 AMPULE 59137-0570-01 — On market View →
Ixinity coagulation factor IX (recombinant) KIT Medexus · NDC 59137-0282-05 · J7213 · 1 KIT in 1 CARTON (59137-282-05) * 5 mL in 1 VIAL (59137-270-01) * 5 mL in 1 SYRINGE (59137-280-01) 59137-0282-05 — On market View →
Ixinity coagulation factor IX (recombinant) KIT Medexus · NDC 59137-0284-05 · J7213 · 1 KIT in 1 CARTON (59137-284-05) * 5 mL in 1 VIAL (59137-272-01) * 5 mL in 1 SYRINGE (59137-280-01) 59137-0284-05 — On market View →
Ixinity coagulation factor IX (recombinant) KIT Medexus · NDC 59137-0289-05 · J7213 · 1 KIT in 1 CARTON (59137-289-05) * 5 mL in 1 VIAL (59137-277-01) * 5 mL in 1 SYRINGE (59137-280-01) 59137-0289-05 — On market View →
Ixinity coagulation factor IX (recombinant) KIT Medexus · NDC 59137-0287-05 · 1 KIT in 1 CARTON (59137-287-05) * 5 mL in 1 VIAL (59137-275-01) * 5 mL in 1 SYRINGE (59137-280-01) 59137-0287-05 — Discontinued View →
Ixinity coagulation factor IX (recombinant) KIT Medexus · NDC 59137-0283-05 · J7213 · 1 KIT in 1 CARTON (59137-283-05) * 5 mL in 1 VIAL (59137-271-01) * 5 mL in 1 SYRINGE (59137-280-01) 59137-0283-05 — On market View →
Ixinity coagulation factor IX (recombinant) KIT Medexus · NDC 59137-0288-05 · 1 KIT in 1 CARTON (59137-288-05) * 5 mL in 1 VIAL (59137-276-01) * 5 mL in 1 SYRINGE (59137-280-01) 59137-0288-05 — Discontinued View →
Rasuvo methotrexate 10 mg/.2mL INJECTION, SOLUTION Medexus · NDC 59137-0510-01 · 1 PACKAGE in 1 CARTON (59137-510-01) / .2 mL in 1 PACKAGE (59137-510-00) 59137-0510-01 — On market View →
Rasuvo methotrexate 17.5 mg/.35mL INJECTION, SOLUTION Medexus · NDC 59137-0525-01 · 1 PACKAGE in 1 CARTON (59137-525-01) / .35 mL in 1 PACKAGE (59137-525-00) 59137-0525-01 — On market View →
Rasuvo methotrexate 30 mg/.6mL INJECTION, SOLUTION Medexus · NDC 59137-0550-01 · 1 PACKAGE in 1 CARTON (59137-550-01) / .6 mL in 1 PACKAGE (59137-550-00) 59137-0550-01 — On market View →
Rasuvo methotrexate 7.5 mg/.15mL INJECTION, SOLUTION Medexus · NDC 59137-0505-01 · 1 PACKAGE in 1 CARTON (59137-505-01) / .15 mL in 1 PACKAGE (59137-505-00) 59137-0505-01 — On market View →
Rasuvo methotrexate 12.5 mg/.25mL INJECTION, SOLUTION Medexus · NDC 59137-0515-01 · 1 PACKAGE in 1 CARTON (59137-515-01) / .25 mL in 1 PACKAGE (59137-515-00) 59137-0515-01 — On market View →
Rasuvo methotrexate 20 mg/.4mL INJECTION, SOLUTION Medexus · NDC 59137-0530-01 · 1 PACKAGE in 1 CARTON (59137-530-01) / .4 mL in 1 PACKAGE (59137-530-00) 59137-0530-01 — On market View →
Rasuvo methotrexate 22.5 mg/.45mL INJECTION, SOLUTION Medexus · NDC 59137-0535-01 · 1 PACKAGE in 1 CARTON (59137-535-01) / .45 mL in 1 PACKAGE (59137-535-00) 59137-0535-01 — On market View →
Rasuvo methotrexate 15 mg/.3mL INJECTION, SOLUTION Medexus · NDC 59137-0520-01 · 1 PACKAGE in 1 CARTON (59137-520-01) / .3 mL in 1 PACKAGE (59137-520-00) 59137-0520-01 — On market View →
Rasuvo methotrexate 25 mg/.5mL INJECTION, SOLUTION Medexus · NDC 59137-0540-01 · 1 PACKAGE in 1 CARTON (59137-540-01) / .5 mL in 1 PACKAGE (59137-540-00) 59137-0540-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.